1007-3418
2012 Issue 3
Antioxidant effects of the Uygur herb, Foeniculum Vulgare Mill, in a rat model of hepatic fibrosis
HANG Ze-gao;LU Xiao-bo;XIAO Lin;TANG Li;ZHANG Li-juan;ZHANG Tao;ZHAN Xin-yu;MA Xiu-min;ZHANG Yue-xin
HANG Ze-gao;LU Xiao-bo;XIAO Lin;TANG Li;ZHANG Li-juan;ZHANG Tao;ZHAN Xin-yu;MA Xiu-min;ZHANG Yue-xin
..............page:221-226
Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNα-2a and ribavirin
HUANG Yan-xiang;CHEN Xin-yue;MA Li-na;YIN Ji-ming;REN Shan;GUO Dan-dan;ZHENG Yan-hong
HUANG Yan-xiang;CHEN Xin-yue;MA Li-na;YIN Ji-ming;REN Shan;GUO Dan-dan;ZHENG Yan-hong
..............page:216-220
..............page:161-162
Histone deacetylase inhibitor MS-275 treatment alters immune molecule content and categories in hepatocarcinoma exosomes
LI Qiu-wen;XIAO Wen-hua;Saren Gaowa;DONG Wei-wei;ZHAO Hui-xia;DUAN Xin-yu;ZHU Jian-hua;KANG Huan-rong;FU Yan;HAO Yi-xin;WANG Ru-liang;SONG Lin-ping;YE Ming.
LI Qiu-wen;XIAO Wen-hua;Saren Gaowa;DONG Wei-wei;ZHAO Hui-xia;DUAN Xin-yu;ZHU Jian-hua;KANG Huan-rong;FU Yan;HAO Yi-xin;WANG Ru-liang;SONG Lin-ping;YE Ming.
..............page:231-235
..............page:176-177
Rational use of antibiotics in patients with hepatic dysfunction
SHI Guang-feng;HUANG Chong
SHI Guang-feng;HUANG Chong
..............page:182-184
..............page:167-169
Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model
ZHANG Qiong;ZHANG Zhi-xin;FANG Qing;GAO Fu-yun;ZHAO Qiu-ling;YANG Ye;SU Hui-min;LIU Ying-ke
ZHANG Qiong;ZHANG Zhi-xin;FANG Qing;GAO Fu-yun;ZHAO Qiu-ling;YANG Ye;SU Hui-min;LIU Ying-ke
..............page:196-200
Clinical characteristics of drug-induced liver injury in 31 pediatric cases
WANG Shu-zhen;GAO Shan;LIU Yan-min;HUANG Yun-li;CHEN Yi-sen;WANG Xin-xin;LIN Wei;HUANG Chun-yang;LIAO Hui-yu
WANG Shu-zhen;GAO Shan;LIU Yan-min;HUANG Yun-li;CHEN Yi-sen;WANG Xin-xin;LIN Wei;HUANG Chun-yang;LIAO Hui-yu
..............page:193-195
Interferon a-2b treatment of chronic hepatitis C caused by whitehaired one case
LIU San-du;XIE Yong
LIU San-du;XIE Yong
..............page:237
A case of anti-HCV treatment in cirrhosis patient with vitiligo
KANG Hai-yan;WANG Jian-bin;ZHAO Zi-long;WANG Yan;LIU Yan-hua
KANG Hai-yan;WANG Jian-bin;ZHAO Zi-long;WANG Yan;LIU Yan-hua
..............page:236
Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus
HAN Guo-rong;JIANG Hong-xiu;WANG Gen-ju;YUE Xin;WANG Cui-min;KAN Nai-ying;WU Min-min
HAN Guo-rong;JIANG Hong-xiu;WANG Gen-ju;YUE Xin;WANG Cui-min;KAN Nai-ying;WU Min-min
..............page:201-205
Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases
CHEN Jing;DUAN Zhong-ping;BAI Li;ZHAO Jun;DING Mei;TONG Xin-yuan;CONG Yu-long
CHEN Jing;DUAN Zhong-ping;BAI Li;ZHAO Jun;DING Mei;TONG Xin-yuan;CONG Yu-long
..............page:206-210
Mechanisms of drug-induced liver injury
LI Zi-jun;XIE Zi-jun
LI Zi-jun;XIE Zi-jun
..............page:163-166
Cognition and perplexity on adaptation and tolerance of drug-induced liver injury
XU Jian-ming;CAI Yi
XU Jian-ming;CAI Yi
..............page:178-181
The diagnosis and treatment of drug-induced liver injury
CHEN Dong-feng;SUN Wen-jing;XIONG Ji
CHEN Dong-feng;SUN Wen-jing;XIONG Ji
..............page:170-172
The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis
SHEN Li-juan;GUO Wei;GAO Ping;YU Jie;QIAN Zhong-yi;ZHANG Hua-xian;ZHANG Zong-ji
SHEN Li-juan;GUO Wei;GAO Ping;YU Jie;QIAN Zhong-yi;ZHANG Hua-xian;ZHANG Zong-ji
..............page:227-230
Chinese herb and drug-induced liver injury
HU Yi-yang,;HUANG Fu
HU Yi-yang,;HUANG Fu
..............page:173-175
..............page:175,210,220
Set up drug lymphocyte stimulation test (3H-TdR) and observe it\'s application in drug-induced liver injury
CHEN Gao-yan;CHEN Cheng-wei;FU Qing-chun;WANG Xiao-jin;NI Liu-da;JIANG Xiao-hua;ZHOU Feng;SHI Li-qin;LAI Rong-tao;YANG Jun
CHEN Gao-yan;CHEN Cheng-wei;FU Qing-chun;WANG Xiao-jin;NI Liu-da;JIANG Xiao-hua;ZHOU Feng;SHI Li-qin;LAI Rong-tao;YANG Jun
..............page:190-192
Clinical and pathological features in 138 cases of drug-induced liver injury
LAI Rong-tao;WANG Hui;GUI Hong-lian;YE Min-zhen;DAI Wei-jia;XIANG Xiao-gang;ZHAO Gang-de;WANG Wei-jing;XIE Qing
LAI Rong-tao;WANG Hui;GUI Hong-lian;YE Min-zhen;DAI Wei-jia;XIANG Xiao-gang;ZHAO Gang-de;WANG Wei-jing;XIE Qing
..............page:185-189
Signaling pathways in activated hepatic stellate cells
OUYANG Yang-yang;GUO Jin-sheng
OUYANG Yang-yang;GUO Jin-sheng
..............page:238-240
Effect of hepatitis B virus X protein on the cell cycle of primary mouse hepatocytes
CAI Yuan;HE Song;LUO Na;LUO Li;GONG Qian
CAI Yuan;HE Song;LUO Na;LUO Li;GONG Qian
..............page:211-215